Pemetrexed/cisplatin

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Pemetrexed/cisplatin, covering 2014-05-21 to 2023-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Mesothelioma Avastin Plus Pemetrexed-cisplatin Study [Phase 2, Phase 3]